Protein (1)
Launched (1)
Human (1)
His Tag (1)
PE Labeled (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
HLH-HP2H4 | HEK293 | PE-Labeled Human HLA-A*11:01&B2M&HPV16-E6 (TTLEQQYNK) Tetramer Protein |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Mavrilimumab | CAM-3001; KPL-301; GM-CSFR; CAM3001 | Phase 3 Clinical | Csl Ltd | Pneumonia; Giant Cell Arteritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) | Details |
| CSF2RA gene-corrected macrophages(University of South Florida) | Phase 2 Clinical | Russian Academy Of Medical Sciences | Pulmonary Alveolar Proteinosis | Details | |
| STSA-1005 | STSA-1005; STSA1005 | Phase 1 Clinical | Coronavirus Disease 2019 (COVID-19) | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



